关于治疗的最新研究趋势
1Department of Surgery, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea.
Journal of the anus, rectum and colon
|April 30, 2025
概括
治疗的最新进展包括新的草药,改进的办公室程序,如带绑定,以及微创的选择,如栓塞. 需要进一步的研究来比较这些不断发展的治疗方法.
科学领域:
- 胃肠病学 胃肠病学
- 结肠直肠手术 结肠直肠手术
- 医疗技术 医疗技术 医学技术
背景情况:
- 的症状和严重程度各不相同,需要不同的治疗策略.
- 新型治疗方法的不断出现使治疗选择变得复杂.
- 对最近的进展有全面的了解对于最佳的患者护理至关重要.
研究的目的:
- 审查和分析过去五年来治疗的最新进展.
- 为不断发展的保守,干预和外科手术方法提供见解.
- 为了指导未来的研究和临床实践在管理.
主要方法:
- 文献综述,重点关注过去五年内发表的研究.
- 分析保守 (草药),办公室 (绑定装置,硬化疗法,基于能源的方法) 和手术治疗 (瘤切除术,动脉绑定) 的创新.
- 探索新兴技术,如内镜办公室治疗和栓塞.
主要成果:
- 保守治疗侧重于隔离活性植物成分.
- 基于办公室的干预措施包括先进的带装置和泡硬化疗法 (Polidocanol).
- 至少侵入性的选择,如内镜治疗和栓塞正在获得引力,特别是在高风险患者. 手术技术正在向部分切除和多普勒独立动脉绑定发展.
结论:
- 治疗正在迅速发展,具有创新的保守和干预选择.
- 新兴技术提供了更安全的替代方案,特别是在复杂的情况下.
- 进一步的比较研究,协议的标准化和成本效益分析对于基于证据的实践至关重要.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
57
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
57
Esophageal Varices-II: Clinical Features and Management
23
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
23
Irritable Bowel Syndrome III: Medical and Nursing Management
113
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
113
Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117
Inflammatory Bowel Disease IV: Pharmacological Management
79
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
79
Drugs for Treatment of Constipation-Predominant IBS
109
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
109


